
Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: A pilot study
Author(s) -
Silvia Sookoian,
María Alejandra Fernández,
Gustavo Osvaldo Castaño
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i48.7560
Subject(s) - medicine , losartan , gastroenterology , fibrosis , liver function , chronic hepatitis , ribavirin , angiotensin ii , blood pressure , immunology , virus
To evaluate the safety and efficacy of chronic administration of losartan on hepatic fibrosis in chronic hepatitis C patients.